KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in Net LoansDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Omega Healthcare Investors (OHI) Gains from Sales and Divestitures (2018 - 2025)

Omega Healthcare Investors' Gains from Sales and Divestitures history spans 9 years, with the latest figure at $305120.0 for Q4 2025.

  • On a quarterly basis, Gains from Sales and Divestitures rose 21.34% to $305120.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $305120.0, a 21.34% increase, with the full-year FY2025 number at $305120.0, up 21.34% from a year prior.
  • Gains from Sales and Divestitures hit $305120.0 in Q4 2025 for Omega Healthcare Investors, up from $251457.0 in the prior quarter.
  • Over the last five years, Gains from Sales and Divestitures for OHI hit a ceiling of $305120.0 in Q4 2025 and a floor of $148538.0 in Q4 2021.
  • Historically, Gains from Sales and Divestitures has averaged $235038.3 across 3 years, with a median of $251457.0 in 2024.
  • Biggest five-year swings in Gains from Sales and Divestitures: decreased 19.48% in 2021 and later rose 21.34% in 2025.
  • Tracing OHI's Gains from Sales and Divestitures over 3 years: stood at $148538.0 in 2021, then soared by 69.29% to $251457.0 in 2024, then increased by 21.34% to $305120.0 in 2025.
  • Business Quant data shows Gains from Sales and Divestitures for OHI at $305120.0 in Q4 2025, $251457.0 in Q4 2024, and $148538.0 in Q4 2021.